Xu Yue Selected Research

Xu Yue Research Topics

Disease

5	Pain (Aches) 10/2023 - 04/2008
4	Hyperalgesia 01/2022 - 07/2017
3	Chronic Pain 01/2023 - 07/2006
2	Neuralgia (Stump Neuralgia) 01/2023 - 01/2022
2	Migraine Disorders (Migraine) 01/2022 - 07/2017
2	COVID-19 01/2021 - 10/2020
2	Parkinson Disease (Parkinson's Disease) 09/2011 - 05/2011
2	Alzheimer Disease (Alzheimer's Disease) 12/2005 - 03/2004
1	Neoplasms (Cancer) 11/2023
1	Contracture 10/2023
1	Knee Osteoarthritis 10/2023
1	Rupture 01/2022
1	Secondary Headache Disorders 01/2022
1	Wounds and Injuries (Trauma) 01/2020
1	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2017
1	Cardiac Arrhythmias (Arrythmia) 03/2015
1	Obstructive Sleep Apnea 03/2015
1	Hypoglycemia (Reactive Hypoglycemia) 11/2013
1	Type 2 Diabetes Mellitus (MODY) 11/2013
1	Experimental Autoimmune Neuritis 01/2005
1	Neurodegenerative Diseases (Neurodegenerative Disease) 02/2004
1	Virus Diseases (Viral Diseases) 02/2004

Drug/Important Bio-Agent (IBA)

3	Opioid Analgesics (Opioids)IBA 01/2020 - 04/2008
2	kappa Opioid Receptors (kappa Opioid Receptor)IBA 01/2023 - 07/2017
2	norbinaltorphimineIBA 01/2023 - 07/2017
2	Protein Isoforms (Isoforms)IBA 01/2022 - 01/2020
2	Sumatriptan (Imigran)FDA LinkGeneric 01/2022 - 07/2017
2	ProlactinIBA 01/2022 - 01/2020
2	Morphine (MS Contin)FDA LinkGeneric 04/2008 - 07/2006
2	Analgesics (Analgesic Drugs)IBA 04/2008 - 07/2006
2	Amyloid beta-PeptidesIBA 03/2004 - 02/2004
1	cupric sulfide (CuS)IBA 11/2023
1	Drug CarriersIBA 11/2023
1	Dynorphins (Dynorphin)IBA 01/2023
1	LigandsIBA 01/2023
1	salicylhydroxamic acid (SHAM)IBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	Cabergoline FDA LinkGeneric 01/2022
1	AerosolsIBA 01/2021
1	Carbon DioxideIBA 10/2020
1	Prolactin Receptors (Prolactin Receptor)IBA 01/2020
1	Mitogen-Activated Protein KinasesIBA 07/2017
1	U 0126 (UO 126)IBA 07/2017
1	SmokeIBA 01/2017
1	Therapeutic UsesIBA 03/2015
1	Insulin (Novolin)FDA Link 11/2013
1	Hemoglobins (Hemoglobin)IBA 11/2013
1	Hypoglycemic Agents (Hypoglycemics)IBA 11/2013
1	GlycopeptidesIBA 09/2011
1	Opioid Peptides (Opioid Peptide)IBA 09/2011
1	tyrosyl- glycyl- phenylalanyl- leucyl- (O- lactosyl)serinamideIBA 09/2011
1	Vascular Endothelial Growth Factor BIBA 05/2011
1	Calcitonin Gene-Related PeptideIBA 04/2008
1	Neurotransmitter Agents (Neurotransmitter)IBA 04/2008
1	5- iodo- 3- ((3,5- dibromo- 4- hydroxyphenyl)methylene)- 2- indolinoneIBA 04/2008
1	Estrogens (Estrogen)FDA Link 12/2005
1	Flecainide (Tambocor)FDA LinkGeneric 01/2005
1	Sodium Channels (Sodium Channel)IBA 01/2005
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 03/2004
1	Death Domain ReceptorsIBA 02/2004

Therapy/Procedure

3	Therapeutics 01/2022 - 07/2017
1	Drug Therapy (Chemotherapy) 11/2023
1	Acupuncture Therapy 10/2023
1	Ligation 01/2023
1	Fracture Fixation 01/2022
1	Continuous Positive Airway Pressure 03/2015
1	Glycemic Control 11/2013
1	Drug Tapering 11/2013
1	Denervation 09/2011